fig2
![Harnessing genetically engineered cell membrane-derived vesicles as biotherapeutics](https://image.oaes.cc/fdff9f70-f6a1-4c58-b9d7-a05d25a9b407/evcna5058.fig.2.jpg)
Figure 2. Applications in treatment of common diseases model with genetically engineered CMVs. Genetically engineered CMVs work through an overexpressed proteins or nucleic acid which function as a targeting molecules, biotherapeutics, or immune modulators in therapy for tumors, systemic lupus erythematosus, diabetes, and cardiovascular diseases. CMVs: cell membrane-derived vesicles.